日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients

VICTOR-6 真实世界观察性研究对老年转移性乳腺癌 (MBC) 患者节拍化疗的最终结果

Trevisan, B; Pepe, F F; Vallini, I; Montagna, E; Amoroso, D; Berardi, R; Butera, A; Cagossi, K; Cavanna, L; Ciccarese, M; Cinieri, S; Cretella, E; De Conciliis, E; Febbraro, A; Ferraù, F; Ferzi, A; Baldelli, A; Fontana, A; Gambaro, A R; Garrone, O; Gebbia, V; Generali, D; Gianni, L; Giovanardi, F; Grassadonia, A; Leonardi, V; Sarti, S; Musolino, A; Nicolini, M; Putzu, C; Riccardi, F; Santini, D; Sarobba, M G; Schintu, M G; Scognamiglio, G; Spadaro, P; Taverniti, C; Toniolo, D; Tralongo, P; Turletti, A; Valenza, R; Valerio, M R; Vici, P; Clivio, L; Torri, V; Cazzaniga, M E

MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study

基于microRNA的特征谱影响卵巢癌的临床进程和生物学:一项miRNA组学研究

Krasniqi, E; Sacconi, A; Marinelli, D; Pizzuti, L; Mazzotta, M; Sergi, D; Capomolla, E; Donzelli, S; Carosi, M; Bagnato, A; Gamucci, T; Tomao, S; Natoli, C; Marchetti, P; Grassadonia, A; Tinari, N; De Tursi, M; Vizza, E; Ciliberto, G; Landi, L; Cappuzzo, F; Barba, M; Blandino, G; Vici, P

Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study

节拍化疗(mCHT)治疗转移性三阴性乳腺癌(TNBC)患者:VICTOR-6 研究结果

Cazzaniga, M E; Vallini, I; Montagna, E; Amoroso, D; Berardi, R; Butera, A; Cagossi, K; Cavanna, L; Ciccarese, M; Cinieri, S; Cretella, E; De Conciliis, E; Febbraro, A; Ferraù, F; Ferzi, A; Baldelli, A; Fontana, A; Gambaro, A R; Garrone, O; Gebbia, V; Generali, D; Gianni, L; Giovanardi, F; Grassadonia, A; Leonardi, V; Marchetti, P; Sarti, S; Musolino, A; Nicolini, M; Putzu, C; Riccardi, F; Santini, D; Saracchini, S; Sarobba, M G; Schintu, M G; Scognamiglio, G; Spadaro, P; Taverniti, C; Toniolo, D; Tralongo, P; Turletti, A; Valenza, R; Valerio, M R; Vici, P; Di Mauro, P; Cogliati, V; Capici, S; Clivio, L; Torri, V

Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation"

关于“循环癌症干细胞衍生的细胞外囊泡作为临床结果评估的新型生物标志物”的更正

Brocco, D; Lanuti, P; Simeone, P; Bologna, G; Pieragostino, D; Cufaro, M C; Graziano, V; Peri, M; Di Marino, P; De Tursi, M; Grassadonia, A; Rapposelli, I G; Pierdomenico, L; Ercolino, E; Ciccocioppo, F; Del Boccio, P; Marchisio, M; Natoli, C; Miscia, S; Tinari, N

Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation.

循环癌干细胞衍生的细胞外囊泡作为临床结果评估的新型生物标志物

Brocco D, Lanuti P, Simeone P, Bologna G, Pieragostino D, Cufaro M C, Graziano V, Peri M, Di Marino P, De Tursi M, Grassadonia A, Rapposelli I G, Pierdomenico L, Ercolino E, Ciccocioppo F, Del Boccio P, Marchisio M, Natoli C, Miscia S, Tinari N